Aubagio (Teriflunomide): An Oral Immunomodulator for MS

By Dr. Emily Hanover

Aubagio (Teriflunomide): An Oral Immunomodulator for Multiple Sclerosis is a comprehensive guide for patients, caregivers, and healthcare professionals seeking to understand the role of Aubagio in managing multiple sclerosis (MS). Written with a focus on clarity and scientific accuracy, this book explores the pathophysiology of MS, the mechanism of action of Aubagio, and its place within the broader landscape of disease-modifying therapies.

Through detailed explanations and evidence-based insights, this book covers key topics, including clinical trials, dosing guidelines, side effect management, and monitoring requirements. Readers will gain a deeper understanding of how Aubagio works to reduce immune cell proliferation, slow disease progression, and improve patient outcomes.

With real-world case studies, comparisons to other MS therapies, and the latest research on the future of oral immunomodulators, this book serves as an essential resource for those navigating MS treatment decisions. Whether you are a newly diagnosed patient, a seasoned healthcare provider, or a researcher in the field, this book offers valuable knowledge to help make informed choices about MS management.

• Format: Paperback
• Language: English
• ISBN: B0F141GJD2
• ISBN13: 9798313705200
• Release Date: March 2025
• Publisher: Independently Published
• Length: 252 Pages
• Weight: 0.75 lbs.
• Dimensions: 0.5" x 6.0" x 9.0"